Clinical Trials on Cancer Malignancies in United States
Total 24607 results
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
Eisai Inc.CompletedSolid Tumor Malignancies, CancerUnited States
-
AstraZenecaTerminatedSolid Tumors | Advanced Solid Malignancies | Cancer,United States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
MedImmune LLCCompletedCancer | B-cell MalignanciesUnited States, Italy, Belgium, Canada, Spain
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedCancer MalignanciesUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Kiromic, Inc.WithdrawnCancer | Hematologic MalignanciesUnited States
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)CompletedHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
Kah Poh LohWithdrawn
-
Dartmouth-Hitchcock Medical CenterRecruitingCancer | Hematologic Malignancy | Blood Cancer | Tumor, SolidUnited States
-
University of Wisconsin, MadisonPfizerCompletedSolid Malignancies | Metastatic Castrate-resistant Prostate CancerUnited States
-
AgennixTerminatedMalignanciesUnited States
-
Stanford UniversityCompletedLeukemia | Blood CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedPancreatic Cancer | Unresectable Biliary-pancreatic MalignanciesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematopoietic/Lymphoid CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic/Lymphoid CancerUnited States
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
Bristol-Myers SquibbCompletedAdvanced MalignanciesUnited States
-
Case Comprehensive Cancer CenterCompletedHepatic MalignanciesUnited States
-
Metronome TherapeuticsUnknownNonhematologic MalignanciesUnited States
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
Massachusetts General HospitalClinical GenomicsWithdrawnGastrointestinal MalignanciesUnited States
-
University of Southern CaliforniaTerminated
-
Novartis PharmaceuticalsCompletedAdvanced MalignanciesUnited States
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Gastrointestinal MalignanciesUnited States
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
University of PittsburghAmerican College of Radiation OncologyNot yet recruitingUpper Abdominal MalignanciesUnited States
-
Summa Health SystemTerminatedAdvanced Bulky MalignanciesUnited States
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
Weill Medical College of Cornell UniversityTerminatedSolid Tumor MalignanciesUnited States
-
Pathway Therapeutics, Inc.Completed
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
Esanex Inc.Completed
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnAdvanced Nonhematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
University of KentuckyArno TherapeuticsCompleted
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Symphony Evolution, Inc.Completed
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States